Page 370 - 20dynamics of cancer
P. 370

REFERENCES                                                  355

                              Sell, S. 2004. Stem cell origin of cancer and differentiation therapy. Critical
                                Reviews in Oncology/Hematology 51:1–28.
                              Sergeyev, A. S. 1975. On the mutation rate of neurofibromatosis. Humangenetik
                                28:129–138.
                              Shibata, D. 2006. Clonal diversity in tumor progression. Nature Genetics 38:402–
                                403.
                              Shibata, D., and Tavare, S. 2006. Counting divisions in a human somatic cell
                                tree: how, what and why? Cell Cycle 5:610–614.
                              Shimodaira, H., Filosi, N., Shibata, H., Suzuki, T., Radice, P., Kanamaru, R., Friend,
                                S. H., Kolodner, R. D., and Ishioka, C. 1998. Functional analysis of human
                                MLH1 mutations in Saccharomyces cerevisiae. Nature Genetics 19:384–389.
                              Shizuru, J. A., Negrin, R. S., and Weissman, I. L. 2005. Hematopoietic stem and
                                progenitor cells: clinical and preclinical regeneration of the hematolymphoid
                                system. Annual Review of Medicine 56:509–538.
                              Shmookler Reis, R. J., and Goldstein, S. 1982. Variability of DNA methylation
                                patterns during serial passage of human diploid fibroblasts. Proceedings of
                                the National Academy of Sciences of the United States of America 79:3949–
                                3953.
                              Sieber, O., Heinimann, K., and Tomlinson, I. P. 2005. Genomic stability and
                                tumorigenesis. Seminars in Cancer Biology 15:61–66.
                              Siegel, D. H., and Sybert, V. P. 2006. Mosaicism in genetic skin disorders. Pedi-
                                atric Dermatology 23:87–92.
                              Simon, R., Eltze, E., Schafer, K. L., Burger, H., Semjonow, A., Hertle, L., Dockhorn-
                                Dworniczak, B., Terpe, H. J., and Bocker, W. 2001. Cytogenetic analysis of
                                multifocal bladder cancer supports a monoclonal origin and intraepithelial
                                spread of tumor cells. Cancer Research 61:355–362.
                              Singh, S. K., Clarke, I. D., Hide, T., and Dirks, P. B. 2004. Cancer stem cells in
                                nervous system tumors. Oncogene 23:7267–7273.
                              Slaga, T. J., Budunova, I. V., Gimenez-Conti, I. B., and Aldaz, C. M. 1996. The
                                mouse skin carcinogenesis model. Journal of Investigative Dermatology. Sym-
                                posium Proceedings 1:151–156.
                              Slaughter, D. P., Southwick, H. W., and Smejkal, W. 1953. Field cancerization
                                in oral stratified squamous epithelium; clinical implications of multicentric
                                origin. Cancer 6:963–968.
                              Smalley, K. S., Brafford, P. A., and Herlyn, M. 2005. Selective evolutionary pres-
                                sure from the tissue microenvironment drives tumor progression. Seminars
                                in Cancer Biology 15:451–459.
                              Smith, G. H. 2005. Label-retaining epithelial cells in mouse mammary gland
                                divide asymmetrically and retain their template DNA strands. Development
                                132:681–687.
                              Sommer, L. 2005. Checkpoints of melanocyte stem cell development. Science’s
                                STKE 2005:pe42.
   365   366   367   368   369   370   371   372   373   374   375